Pancreatic Fistula Clinical Trial
Official title:
Randomised Prospective Study of Clinical Outcomes After Closed Suction Drainage and Natural Drainage of the Pancreatic Duct in Pancreaticojejunostomy After Pancreatoduodenectomy
Pancreaticojejunal anastomosis leakage is a major complication after pancreatoduodenectomy and various technical methods have been examined to improve the situation.However, none of methods have been successful at improving results according to the findings of prospective randomized studies. We propose that active drainage of pancreatic juice using suction drainage might maximize the advantage of a stent and finally reduce pancreaticojejunal anastomosis leakage.
Pancreaticojejunal anastomosis leakage is a major complication after pancreatoduodenectomy
and various technical methods have been examined to improve the situation, e.g., pancreatic
duct occlusion, anastomosis reinforcement with fibrin glue, placement of an internal stent,
and pancreaticogastrostomy. However, none of these methods have been successful at improving
results according to the findings of prospective randomized studies. Some retrospective
studies have reported a low pancreatic fistula rate when a catheter is inserted into the
pancreatic duct to externally drain pancreatic juice. Furthermore, a recent prospective
randomized trial showed that external drainage of the pancreatic duct decreased the rate of
pancreatic fistula formation indicating that diverting pancreatic juice from an anastomosis
can theoretically reduce the incidence of pancreaticojejunostomy anastomotic leakage. We
propose that active drainage of pancreatic juice using suction drainage might maximize the
advantage of a stent and finally reduce pancreaticojejunal anastomosis leakage.
We will enroll all patients who underwent duct-to-mucosa pancreaticojejunostomy
reconstruction after pancreatoduodenectomy, and randomly allocate them to two groups of
closed suction drainage group (CD group) and natural drainage group (ND group) just after
operations.
Preoperative demographic and clinical data, and surgical procedure, pathologic diagnosis,
postoperative course and complications details were collected prospectively.
The primary study endpoints were; pancreatic fistula rates, severity of pancreatic fistulas,
postoperative complications, postoperative length of hospital stay, and hospital mortality
rate. Pancreatic fistula was defined as any measurable drainage from an operatively placed
drain (or a subsequently placed percutaneous drain) on or after postoperative day 3, with an
amylase content greater than 3 times the upper limit of normal serum amylase level (i.e.,
>300 IU/L)(International Study Group for Pancreatic Fistulas (ISGPF) definition) or on or
after postoperative week 1 drainage of more than 30 mL of fluid with an amylase level higher
than 600 U/dL(Seoul National University Hospital (SNUH) definition). In addition, fistula
severity was graded as A, B, C according to ISGPF clinical criteria as follows; grade A
fistula - a transient, asymptomatic fistula with only elevated drain amylase levels and
treatments or deviation in clinical management are not required; grade B fistula - a
symptomatic, clinically apparent fistula requiring diagnostic evaluation and therapeutic
management; and grade C fistula - a severe, clinically significant fistula requiring a major
deviations in clinical management and unequivocal aggressive therapeutic interventions.
Major pancreatic leakage was defined as drainage of more than 200 mL of fluid or the
development of an intra-abdominal abscess.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01696903 -
Evaluation of a Novel Pancreaticojejunostomy Technique for Pancreaticoduodenectomy
|
N/A | |
Completed |
NCT01301222 -
Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas
|
Phase 4 | |
Recruiting |
NCT05155878 -
Prognostic Factors in Periampullary Tumors and Cysts
|
||
Terminated |
NCT03757455 -
ERAS Protocol in Pancreaticoduodenectomy and Total Pancreatectomy
|
N/A | |
Recruiting |
NCT05212350 -
Total pancrEaTectomy vs High-Risk Pancreatic anastomosiS
|
N/A | |
Completed |
NCT04609137 -
Early Drain Removal Versus Standard Drain Management After Distal Pancreatectomy (Early-Dist)
|
N/A | |
Recruiting |
NCT04798560 -
Identifing Risk Factors for Pancreaticojejunostomy Leakage Following Pancreaticoduodenectomy
|
||
Completed |
NCT03627559 -
Early Detection of Anastomotic Leakage by Microdialysis Catheters
|
||
Completed |
NCT01550406 -
Use of Polyethylene Glycolic Acid or Tachocomb to Prevent Pancreatic Fistula Following Distal Pancreatectomy
|
Phase 4 | |
Recruiting |
NCT04783831 -
Biodegradable Pancreatic Stents for the Prevention of Postoperative Pancreatic Fistula After Cephalic Pancreaticoduodenectomy
|
||
Not yet recruiting |
NCT05387538 -
One-layer Versus Two-layer Duct-to-mucosa Pancreaticojejunostomy After Pancreaticoduodenectomy .
|
N/A | |
Active, not recruiting |
NCT02775227 -
HYPAR Trial - Hydrocortisone vs. Pasireotide in Reducing Pancreatic Surgery Complications
|
Phase 4 | |
Completed |
NCT02790333 -
Different Stapler Cartridge For Pancreatic Stump Texture To Prevent Pancreatic Fistula
|
N/A | |
Not yet recruiting |
NCT05657366 -
Peritoneal Lavage on the Incidence of Pancreatic Fistula and Related Complications After Pancreatoduodenectomy
|
N/A | |
Completed |
NCT03419676 -
Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy
|
Phase 3 | |
Recruiting |
NCT05297136 -
Preoperative Endoscopic Pancreatic Stent for Distal Pancreatectomy
|
N/A | |
Completed |
NCT00931554 -
Randomized Trial of Early Versus Standard Drainage Removal After Pancreatic Resections
|
N/A | |
Recruiting |
NCT04380506 -
Validations of New cut-of for the Stratification of Postoperative Complications,Drains Management
|
N/A | |
Recruiting |
NCT06283160 -
Metabolomic and Immune Profiling in the Development of Pancreatic Fistulas After Cephalic Duodenopancreatectomy
|
||
Completed |
NCT02784990 -
Study of Pancreatic Enzymes in the Drains as Early Biomarkers of Post-operative Pancreatic Fistula and Its Clinical Repercussions
|